These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17490827)

  • 1. A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
    Cesaretti JA; Stock RG; Atencio DP; Peters SA; Peters CA; Burri RJ; Stone NN; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1410-6. PubMed ID: 17490827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.
    Cesaretti JA; Stock RG; Lehrer S; Atencio DA; Bernstein JL; Stone NN; Wallenstein S; Green S; Loeb K; Kollmeier M; Smith M; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):196-202. PubMed ID: 15629612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
    Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding.
    Akimoto T; Katoh H; Kitamoto Y; Tamaki T; Harada K; Shirai K; Nakano T
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):364-70. PubMed ID: 16690428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
    Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
    Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer.
    Sherertz T; Wallner K; Merrick G; Ford E; Sutlief S; Cavanagh W; Butler W; True L
    Brachytherapy; 2004; 3(3):130-5. PubMed ID: 15533804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M
    Jpn J Clin Oncol; 2007 Feb; 37(2):121-6. PubMed ID: 17255159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late rectal toxicity after prostate brachytherapy: influence of supplemental external beam radiation on dose-volume histogram analysis.
    Kalakota K; Rakhno E; Pelizzari CA; Jani AB; Liauw SL
    Brachytherapy; 2010; 9(2):131-6. PubMed ID: 19853533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM missense variant P1054R predisposes to prostate cancer.
    Meyer A; Wilhelm B; Dörk T; Bremer M; Baumann R; Karstens JH; Machtens S
    Radiother Oncol; 2007 Jun; 83(3):283-8. PubMed ID: 17502119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel parameter predicting grade 2 rectal bleeding after iodine-125 prostate brachytherapy combined with external beam radiation therapy.
    Shiraishi Y; Hanada T; Ohashi T; Yorozu A; Toya K; Saito S; Shigematsu N
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):182-7. PubMed ID: 23747214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors and management of rectal bleeding side effects following prostate cancer brachytherapy.
    Price JG; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):842-7. PubMed ID: 23845840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis.
    Snyder KM; Stock RG; Hong SM; Lo YC; Stone NN
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):335-41. PubMed ID: 11380219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.
    Valdagni R; Rancati T; Ghilotti M; Cozzarini C; Vavassori V; Fellin G; Fiorino C; Girelli G; Barra S; Zaffaroni N; Pierotti MA; Gariboldi M
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1431-40. PubMed ID: 19211196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
    Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy.
    Andreassen CN; Overgaard J; Alsner J; Overgaard M; Herskind C; Cesaretti JA; Atencio DP; Green S; Formenti SC; Stock RG; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):776-83. PubMed ID: 16338099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Kurko B; Cleavinger S
    Brachytherapy; 2003; 2(3):147-57. PubMed ID: 15062137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.
    Zapatero A; García-Vicente F; Modolell I; Alcántara P; Floriano A; Cruz-Conde A; Torres JJ; Pérez-Torrubia A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1343-51. PubMed ID: 15275719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding.
    Akimoto T; Muramatsu H; Takahashi M; Saito J; Kitamoto Y; Harashima K; Miyazawa Y; Yamada M; Ito K; Kurokawa K; Yamanaka H; Nakano T; Mitsuhashi N; Niibe H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1033-9. PubMed ID: 15519772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.